Zenas Biopharma Inc (NASDAQ: ZBIO) flaunted slowness of -0.74% at $36.31, as the Stock market unbolted on Wednesday, before settling in for the price of $36.58 at the close. Taking a more long-term approach, ZBIO posted a 52-week range of $5.83-$44.60.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 65.63%. This publicly-traded company’s shares outstanding now amounts to $42.21 million, simultaneously with a float of $21.93 million. The organization now has a market capitalization sitting at $1.95 billion. At the time of writing, stock’s 50-day Moving Average stood at $35.24, while the 200-day Moving Average is $19.17.
Zenas Biopharma Inc (ZBIO) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Zenas Biopharma Inc industry. Zenas Biopharma Inc’s current insider ownership accounts for 59.14%, in contrast to 31.11% institutional ownership. According to the most recent insider trade that took place on Oct 09 ’25, this organization’s Director bought 63,158 shares at the rate of 19.00, making the entire transaction reach 1,200,002 in total value, affecting insider ownership by 1,173,395. Preceding that transaction, on Oct 09 ’25, Company’s 10% Owner bought 126,315 for 19.00, making the whole transaction’s value amount to 2,399,985. This particular insider is now the holder of 1,917,895 in total.
Zenas Biopharma Inc (NASDAQ: ZBIO) Trading Performance Indicators
Let’s observe the current performance indicators for Zenas Biopharma Inc (ZBIO). It’s Quick Ratio in the last reported quarter now stands at 5.66. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 129.94.
In the same vein, ZBIO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.53, a figure that is expected to reach -1.00 in the next quarter, and analysts are predicting that it will be -3.95 at the market close of one year from today.
Technical Analysis of Zenas Biopharma Inc (ZBIO)
Now, what If we examine the latest scores posted by [Zenas Biopharma Inc, ZBIO]. During the last 5-days, its volume was lower the volume of 0.26 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 32.20% While, its Average True Range was 42.61.
Raw Stochastic average of Zenas Biopharma Inc (ZBIO) in the period of the previous 100 days is set at 72.56%, which indicates a major rise in contrast to 36.81% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 3.75 that was higher than 2.51 volatility it exhibited in the past 100-days period.
